31,596
edits
Changes
Jump to navigation
Jump to search
→Adverse Effects
*Abdominal pain
*Abdominal pain
*Hallucinations
*Hallucinations
*Loss of hearing
*Itching
*Shaking
*Increased competitiveness and shifts in status relationships: both with people and [more probably] other dogs in the household. Especially important where status related problems already exist.
*Increased competitiveness and shifts in status relationships: both with people and [more probably] other dogs in the household. Especially important where status related problems already exist.
*Pethidine: some serious [fatal] adverse reactions seen in man. Hyperpyrexia, respiratory failure, impaired consciousness, neurological signs.
*Pethidine: some serious [fatal] adverse reactions seen in man. Hyperpyrexia, respiratory failure, impaired consciousness, neurological signs.
*Phenylpropanolamine, Phenylephrine, ephedrine, pseudoephedrine: extreme fluctuations of blood pressure and life-threatening hypertension seen in man.
*Phenylpropanolamine, Phenylephrine, ephedrine, pseudoephedrine: extreme fluctuations of blood pressure and life-threatening hypertension seen in man.
*Amitraz: found in some tick collars
A minimum of a 2 week gap should be allowed between withdrawal of selegiline and initiation of treatment with a tricyclic antidepressant or selective serotonin reuptake inhibitor. Due to the long half-life of fluoxetine and its active metabolites, at least 5 weeks should elapse between discontinuation of fluoxetine and initiation of treatment with selegiline.
A minimum of a 2 week gap should be allowed between withdrawal of selegiline and initiation of treatment with a tricyclic antidepressant or selective serotonin reuptake inhibitor. Due to the long half-life of fluoxetine and its active metabolites, at least 5 weeks should elapse between discontinuation of fluoxetine and initiation of treatment with selegiline.